Status:

UNKNOWN

Russian Current and Expiratory Muscle Training in COPD Patients

Lead Sponsor:

Cairo University

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

MALE

55-65 years

Phase:

NA

Brief Summary

Respiratory muscles are essential to alveolar ventilation. In COPD, these muscles work against increased mechanical loads due to airflow limitation and geometrical changes of the thorax derived from p...

Detailed Description

Chronic Obstructive Pulmonary Disease (COPD) remains the fourth leading cause of chronic morbidity and mortality at the global level, and it represents a major problem for public health. It is known t...

Eligibility Criteria

Inclusion

  • Men with stage II COPD Patients
  • aged from 55 to 65 years' old
  • FEV1/FVC less than 70% (Patients of moderate COPD (Stage II- GOLD criteria) (Rabe et al, 2019)
  • BMI 25.0-29.9 kg/m2 (Pre-obesity)
  • Tobacco smokers
  • No history of infections or symptom exacerbations in the previous two months before the study
  • Did not participate in any selective exercise program for the respiratory muscles before

Exclusion

  • Women
  • Acute exacerbation that requires a change in pharmacological management or hospitalization
  • An open injury affecting the application of surface electrodes of russian current
  • Asthmatic patient.
  • Implanted pacemaker
  • Patients with chest infection.
  • Patients with pleural diseases.
  • Primary valvular disease
  • History of spontaneous pneumothorax
  • Clinically significant peripheral vascular disease
  • Severe anemia
  • BMI more than 29.9 kg/m2
  • Previous lung surgery
  • Long-term oxygen treatment
  • Patients with chronic renal failure.
  • Any cognitive impairment that interferes with prescribed exercise procedures
  • Musculoskeletal or neurological limitation to physical exercise
  • Any patient enrolled in an anther research study for at least 30 days

Key Trial Info

Start Date :

March 15 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2022

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04704479

Start Date

March 15 2021

End Date

April 1 2022

Last Update

March 31 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cairo University

Giza, Egypt, 11432